Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 602

Test Your Knowledge #602: A 70-year-old man who has type 2 diabetes, coronary artery disease, and COPD...

A 70-year-old man who has type 2 diabetes, coronary artery disease, and chronic obstructive pulmonary disease is seen for an annual physical examination.

Advertisement

He notes no health-related concerns and has no acute symptoms. He is eating healthy foods but is unable to perform regular physical activity. His blood pressure is 150/90 mm Hg, hemoglobin A1C value is 8%, LDL cholesterol level is 90 mg/dL (2.33 mmol/L), and serum electrolyte values are within normal range. His current medications are glyburide 10 mg twice daily, simvastatin 40 mg daily, and hydrochlorothiazide 25 mg daily. The physician helps the patient set a specific health goal for the next few weeks (i.e., to walk his dog at least 10 minutes 5 days a week after lunch), adds lisinopril 10 mg daily and metformin 500 mg twice daily to the patient's treatment regimen, and provides counseling and information about these new medications.

Which of the following is the most important additional step for supporting this patient?

A. Ask the patient to schedule an appointment if his health status changes

B. Schedule a follow-up appointment in 1 month

C. Refer him to a community exercise program

D. Refer him to a diabetes educator

Click here for correct answer.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 December, 2011 and appeared in  Issue 602

Past five issues: Diabetes Clinical Mastery Series Issue 247 | Issue 787 | Diabetes Clinical Mastery Series Issue 246 | SGLT-2 Inhibitors Special Edition June 2015 | Issue 786 |

2015 Most Popular Articles:

Triple Therapy Improves Glycemia in Type 1 Diabetes
Posted June 19, 2015
A Dual SGLT1/SGLT2 Inhibitor Can be a Treatment Option in Type 1 Diabetics
Posted June 12, 2015
Canagliflozin and Its Effects on Weight Loss and BP
Posted June 12, 2015
Skin Bacteria a Cause of Diabetes?
Posted June 12, 2015
High Fiber Diets Reduce Risk of Diabetes
Posted June 04, 2015
Blood Biomarkers May Predict Risk of Severe Hypoglycemia
Posted June 12, 2015
Lilly Insulin: A Better Alternative than Lantus?
Posted June 19, 2015
Efficacy and Safety of an SGLT-2 Inhibitor with Insulin for Type 2s
Posted May 28, 2015
Tight Blood Glucose Control and Cardiovascular Disease
Posted June 12, 2015
Reducing Neuropathic Pain with a Vegan Diet
Posted June 04, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Have you recommended the use of an SGLT-2 inhibitor to any of your type 1 patients?